ReSound OMNIA RIE vs Signia Pure C&G IX

The ReSound OMNIA RIE is a premium prescription behind-the-ear hearing aid released in 2022, currently priced at $4,498. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 36 devices in the Prescription Hearing Aid category. This device shows a mixed performance profile in our testing. Its standout strength is speech clarity in quiet environments, scoring 3.7/5—a solid result that sits 0.42 points above the category average. Own-voice comfort also performs above average at 3.0/5, which may appeal to users concerned about how their own voice sounds while wearing hearing aids. However, the OMNIA RIE struggles significantly in challenging listening situations. Speech-in-noise performance scored just 1.0/5, falling 0.96 points below the category average—a notable limitation for users who frequently encounter noisy restaurants, gatherings, or other difficult acoustic environments. Feedback handling, while strong in absolute terms at 4.1/5, also trails the category average by 0.61 points. Music streaming delivers mixed results at 2.7/5, essentially matching the category average. The OMNIA RIE offers versatile connectivity with both iPhone and Android streaming, hands-free calling capability, and the flexibility of both rechargeable and disposable battery options. At its premium price point, however, several competitors in the same price range—including the Phonak Sphere Infinio and Oticon Intent—deliver substantially higher overall scores. This device may suit users who prioritize quiet conversation clarity and own-voice comfort over challenging noise performance.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.